Hatteras Venture Partners is a North Carolina-based venture capital firm that finances biomedical companies.
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 8, 2022
Cardiosense
|
Series A | $15.10M | Artificial Intelligence | Yes |
Nov 1, 2022
Boomerang Medical
|
Series A | $15M | Biotechnology | Yes |
Mar 13, 2017
HistoSonics
|
Series B | $8.26M | Health Care | — |
Aug 19, 2014
Clinverse
|
Series C | $9.10M | Finance | — |
Feb 22, 2010
HistoSonics
|
Series A | $14M | Health Care | Yes |